Yonhap Infomax News2d ago
Samsung Epis Holdings establishes its first global R&D center in Beijing's Changping District to strengthen antibody-drug conjugate development capabilities, with official opening scheduled for June and plans to recruit specialized local talent.
#YonhapInfomax #SamsungEpisHoldings #ADCDevelopment #ChinaRDCenter #BiopharmaceuticalResearch #GlobalExpansion #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=122960
Yonhap Infomax NewsJun 16, 2025
Lotte Biologics has signed an MOU with Exelixis and Cana Therapeutics to jointly develop next-generation ADC cancer therapies, focusing on linker and payload technologies to enhance global competitiveness.
#YonhapInfomax #LotteBiologics #Exelixis #CanaTherapeutics #ADCDevelopment #LinkerPayload #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=67689
Lotte Bio Signs MOU with Exelixis and Cana Therapeutics for ADC Development

Lotte Biologics has signed an MOU with Exelixis and Cana Therapeutics to jointly develop next-generation ADC cancer therapies, focusing on linker and payload technologies to enhance global competitiveness.

Yonhap Infomax